CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF HIV-INFECTED PATIENTS WITH DISCORDANT IMMUNE RESPONSE TO ART IN THE SVERDLOVSK REGION
T.V. Balykchinova¹, V.V. Zhukov¹,²
DOI: 10.22138/2500-0918-2022-19-1-32-40
¹ State budgetary health Institution of Sverdlovsk region «Sverdlovsk Regional Center for the Prevention and Control of AIDS», Yekaterinburg, Russian Federation;
² Ural State Medical University, Yekaterinburg, Russian Federation
Abstract. The aim of the study — to analyze clinical and epidemiological indicators, the chances of death in patients with a discordant immune response in the Sverdlovsk region; to identify the range of values of CD4+ lymphocytes at the beginning of treatment, in which the development of DIR is probably.
Materials and methods. We conducted a cohort retrospective study of HIV-infected patients who were observed in the Sverdlovsk region and had a level of CD4+lymphocytes at the beginning of treatment <350 cl/mcl. Two groups were formed: the main one (DIR) — patients, who had CD4 <350 cl/mcl 1 year after the start of ART and then it never has risen higher; control one — patients, who had CD4 >350 cl /mcl 1 year after the start of ART and then it never has fallen below.
Results. According to the results of the study, we revealed the influence of the following factors on the recovery of CD4+ T-lymphocytes: age — older age prevailed in the group of patients with DIR (Me 39 (Q1-Q3: 35-44)) in relation to patients of the control group (Me 35 (Q1-Q3:31-40)); male sex had a higher chance of DIR (OR 2,058; 95% CI 1,864-2,272); HIV transmission pathway — drug-addicted patients had DIR more often. The risks of death were significantly higher in the group of patients with DIR: from all causes (OR 3,522; 95% CI 3,041-4,079), from HIV-related causes (OR 5,445; 95% CI 4,317-6,867), from non-HIV-related causes (OR 2,426; 95% CI 2,011-2,927). The baseline level of CD4+ lymphocytes before ART in the DIR group was significantly lower (Me 91 (Q1-Q3: 39-154)) in relation to patients of the control group (Me 240 (Q1-Q3: 160-295)). We obtained the threshold value of CD4+ lymphocytes using ROC analysis — 165 cl/µl.It can be used to predict the recovery of CD4+ lymphocytes above 350 cl/µl.
Conclusion. A discordant immune response to ART can be caused by many factors. The level of CD4+lymphocytes before the start of ART strongly affects the immune response and can be used to predict the recovery of CD4+ above 350 cl/µl.
Keywords: HIV infection, CD4-lymphocytes, discordant immune response
There is no conflict of interest.
Contact details of the corresponding author:
Tatiana V. Balykchinova
spilnik.tatyana@yandex.ru
Received 30.12.2021
For citation:
Balykchinova T.V., Zhukov V.V. Clinical and epidemiological characteristics of HIV-infected patients with discordant immune response to art in the Sverdlovsk region. [Online] Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2022, Vol. 19, no. 1, pp.32–40. DOI: 10.22138/2500-0918-2022-19-1-32-40 (In Russ)
REFERENCES
1. Lodwick R. K. et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet (London, England). 2010. Vol. 376. No. 9738. pp. 340-345.DOI: https://doi.org/10.1016/S0140-6736(10)60932-4
2. Shmagel K.V. Discordant response of CD4+ T-lymphocytes to antiretroviral therapy. HIV infection and immunosuppression. 2019. Vol. 11. No. 1. (In Russ.) DOI: https://doi.org/10.22328/2077-9828-2019-11-1
3. Tan R. et al. Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy //JAIDS Journal of Acquired Immune Deficiency Syndromes. 2008. Т. 47. No. 5. pp. 553-558. DOI: https://doi.org/10.1097/qai.0b013e31816856c5
4. Tuboi S.H. et al. Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. Journal of acquired immune deficiency syndromes. – 2010. Vol. 53. No. 1. pp. 70. DOI: https://doi.org/10.1097/QAI.0b013e3181c22d19
5. Zoufaly A. et al. Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. Journal of Infectious Diseases. 2011. Vol. 203. No. 3. pp. 364-371. DOI: https://doi.org/10.1093/jinfdis/jiq055
6. Kelly C. et al. Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes. PloS one. 2016. Vol. 11. No. 6. – pp. e0156099. DOI: https://doi.org/10.1371/journal.pone.0156099
7. Oleinik A. F., Fazylov V. H. Causes of immunological inefficiency of antiretroviral therapy in patients with HIV infection. Kazan Medical Journal. 2014. Vol. 95. No. 4, pp. 581-588 (In Russ.).
8. Yang X. et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non‐responders. Journal of leukocyte biology. 2020. Vol. 107. No. 4. pp. 597-612. DOI: https://doi.org/10.1002/JLB.4MR1019-189R
9. Rajasuriar R. et al. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. PloS one. 2011. Vol. 6. No. 6. p. e20713. DOI: https://doi.org/10.1371/journal.pone.0020713
10. Engsig F. N. et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC infectious diseases. 2010. Vol. 10. No. 1. pp. 1-9. DOI: https://doi.org/10.1186/1471-2334-10-318
11. Serrano-Villar S. et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS pathogens. 2014. Vol. 10. No. 5. p. e1004078. DOI: https://doi.org/10.1371/journal.ppat.1004078
12. Gilson R. et al. Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study. HIV medicine. 2010. Vol. 11. No. 2. pp. 152-160. DOI: https://doi.org/10.1111/j.1468-1293.2009.00755.x.
13. Zeng M. et al. Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy. PLoS pathogens. 2012. Vol. 8. No. 1. p. e1002437. DOI: https://doi.org/10.1371/journal.ppat.1002437
14. Li C. X. et al. The predictive role of CD4+ cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China. BMC immunology. 2019. Vol. 20. No. 1. pp. 1-8. DOI: https://doi.org/10.1186/s12865-019-0311-2
Authors
Tatiana V. Balykchinova
Sverdlovsk Regional Center for the Prevention and Control of AIDS
Infectious diseases doctor
Russian Federation, Yekaterinburg, 620102, Yasnaya str., 46
spilnik.tatyana@yandex.ru
Vyacheslav V. Zhukov
Sverdlovsk Regional Center for the Prevention and Control of AIDS
Russian Federation, Yekaterinburg, 620102, Yasnaya str., 46
Ural State Medical University
Russian Federation 620014 Yekaterinburg Repin str. 3
Candidate of Science (Medicine), Doctor of Medical and Social expertise.
slavaic@list.ru
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)